In the latest trading session, Exact Sciences (EXAS) closed at $63.24, marking a -0.46% move from the previous day.

Gilead Sciences is set to announce its Q1 earnings results on April 25th. Analysts predict a -$1.54 EPS and $6.35B in revenue ...

Gilead Sciences’ stock underperformed market substantially over past decade. It offers a high 4.61% dividend yield. Read my ...

Palisade Bio announced a strategic collaboration with Strand Life Sciences today. Palisade Bio stock opened a whopping 50% up ...

Currently, records show that 15.76 million of the company’s shares remain outstanding. The insiders hold 7.32% of outstanding ...

Gilead Sciences will present their latest quarterly figures.Analysts expect losses per share of $1.513.Go here to follow Gilead ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $18.0, with a high ...

Fintel reports that on April 24, 2024, HSBC upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Reduce to Hold. ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The S&P 500 Index ($SPX) (SPY) this morning is down -1.42%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -1.43%, and ...